7Baggers

Cushman & Wakefield plc Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
 Long-Term Debt  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 00.460.931.391.852.312.783.24Billion

Cushman & Wakefield plc Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 
                               
  assets                             
  current assets:                             
  cash and cash equivalents618,200,000 623,200,000 793,300,000 775,400,000 567,300,000 553,500,000 767,700,000 588,200,000 502,300,000 459,600,000 644,500,000 380,800,000 476,700,000 611,900,000 770,700,000 1,188,500,000 1,073,200,000 1,015,600,000 1,074,800,000 916,800,000 875,500,000 379,500,000 813,200,000 400,100,000 423,700,000 411,000,000 895,300,000 939,000,000 382,400,000 
  trade and other receivables, net of allowance of 89.8 and 88.7, as of june 30, 2025 and december 31, 2024, respectively1,394,700,000                             
  income tax receivable83,600,000 121,000,000 62,100,000 65,500,000 67,500,000 86,400,000 67,100,000 113,700,000 144,800,000 62,000,000 55,400,000 31,300,000 35,400,000 32,000,000 30,000,000 39,700,000 41,000,000 40,900,000 43,500,000 35,000,000 36,600,000 35,400,000 39,000,000 43,700,000 39,500,000 38,000,000 41,100,000 11,000,000 11,400,000 
  short-term contract assets310,700,000 303,800,000 301,400,000 302,000,000 296,700,000 317,000,000 311,000,000 343,500,000 374,600,000 360,000,000 358,200,000 392,500,000 431,400,000 360,600,000 318,900,000 294,600,000 274,000,000 250,400,000 247,600,000           
  prepaid expenses and other current assets229,900,000 249,600,000 181,200,000 227,900,000 229,100,000 237,000,000 189,400,000 213,200,000 266,800,000 298,200,000 246,300,000 275,300,000 277,500,000 295,700,000 264,700,000 268,600,000 270,800,000 250,200,000 223,200,000   559,000,000 484,400,000 494,000,000 438,500,000 312,200,000 343,400,000 373,900,000 339,700,000 
  total current assets2,637,100,000 2,604,800,000 2,690,400,000 2,648,900,000 2,592,000,000 2,459,800,000 2,803,200,000 2,618,200,000 2,624,600,000 2,506,300,000 2,766,800,000 2,403,300,000 2,761,400,000 2,672,900,000 2,830,300,000 3,076,200,000 2,845,600,000 2,718,300,000 2,890,700,000 2,709,600,000 2,630,800,000 2,218,500,000 2,860,800,000 2,289,800,000 2,264,100,000 2,132,100,000 2,743,300,000 2,623,800,000 2,079,400,000 
  property and equipment123,800,000 126,000,000 136,000,000 141,600,000 148,200,000 155,100,000 163,800,000 160,300,000 166,000,000 169,700,000 172,600,000 156,100,000 180,600,000 192,400,000 194,600,000 194,000,000 207,800,000 224,100,000 235,900,000 243,300,000 255,700,000 274,000,000 299,400,000 288,200,000 299,600,000 306,900,000 313,800,000 295,600,000 289,500,000 
  goodwill2,059,700,000 2,020,800,000 1,998,300,000 2,049,400,000 2,024,000,000 2,064,300,000 2,080,900,000 2,052,400,000 2,073,300,000 2,066,800,000 2,065,500,000 2,020,500,000 2,050,400,000 2,084,300,000 2,081,900,000 2,076,000,000 2,091,700,000 2,091,700,000 2,098,000,000 2,059,500,000 2,035,100,000 2,009,600,000 1,969,100,000 1,930,700,000 1,950,300,000 1,946,900,000 1,778,500,000 1,771,000,000 1,750,200,000 
  intangible assets674,500,000 682,400,000 690,100,000 703,200,000 711,900,000 791,300,000 805,900,000 822,800,000 841,000,000 857,800,000 874,500,000 885,400,000 899,000,000 908,100,000 922,200,000 937,400,000 956,400,000 972,700,000 991,200,000 991,800,000 1,023,800,000 1,062,700,000 1,062,600,000 1,093,600,000 1,146,500,000 1,193,100,000 1,128,200,000 1,166,500,000 1,203,900,000 
  equity method investments731,900,000 735,400,000 723,600,000 723,500,000 710,500,000 713,600,000 708,000,000 693,500,000 681,900,000 685,700,000 677,300,000 659,400,000 657,200,000 654,400,000 641,300,000 125,100,000 122,300,000 115,800,000 114,900,000 108,100,000 105,300,000 105,100,000 7,900,000 8,000,000 9,800,000 9,300,000 8,700,000 8,100,000 7,300,000 
  deferred tax assets135,900,000 65,100,000 93,100,000 124,200,000 109,300,000 99,800,000 67,400,000 74,700,000 57,100,000 58,100,000 58,600,000 77,600,000 62,700,000 65,000,000 65,500,000 60,300,000 61,000,000 60,600,000 61,400,000 84,700,000 82,800,000 79,700,000 86,600,000 80,900,000 84,100,000 84,700,000 84,000,000 67,400,000 68,600,000 
  non-current operating lease assets276,300,000 279,300,000 290,100,000 303,700,000 307,800,000 320,300,000 339,000,000 327,600,000 345,800,000 355,500,000 358,000,000 345,300,000 377,900,000 398,700,000 413,500,000 434,700,000 405,600,000 405,700,000 438,200,000 444,800,000 450,600,000 470,800,000 490,700,000 502,800,000 525,400,000 531,600,000    
  other non-current assets916,200,000 893,700,000 927,600,000 839,500,000 739,300,000 886,900,000 805,800,000 832,900,000 850,400,000 921,800,000 976,000,000 1,074,000,000 744,600,000 780,300,000 741,100,000 572,600,000 565,600,000 541,900,000 507,600,000 486,600,000 492,100,000 399,000,000 386,300,000 460,400,000 479,100,000 502,900,000 489,500,000 500,000,000 447,800,000 
  total assets7,555,400,000 7,407,500,000 7,549,200,000 7,534,000,000 7,343,000,000 7,491,100,000 7,774,000,000 7,582,400,000 7,640,100,000 7,621,700,000 7,949,300,000 7,621,600,000 7,733,800,000 7,756,100,000 7,890,400,000 7,476,300,000 7,256,000,000 7,130,800,000 7,337,900,000 7,128,400,000 7,076,200,000 6,619,400,000 7,163,400,000 6,654,400,000 6,758,900,000 6,707,500,000 6,546,000,000 6,432,400,000 5,846,700,000 
  liabilities and shareholders’ equity                             
  current liabilities:                             
  short-term borrowings and current portion of long-term debt174,800,000 108,500,000 103,200,000 96,400,000 141,700,000 125,000,000 149,700,000 118,900,000 36,700,000 33,700,000 49,800,000 46,300,000 44,500,000 43,300,000 42,400,000 41,300,000 39,000,000 40,000,000 39,700,000 37,400,000 38,100,000 38,800,000 39,300,000 40,300,000 40,100,000 38,700,000 39,900,000 40,600,000 40,300,000 
  accounts payable and accrued expenses1,147,200,000 1,095,100,000 1,110,500,000 1,068,600,000 1,032,400,000 1,093,600,000 1,157,700,000 1,113,500,000 1,125,200,000 1,132,300,000 1,199,000,000 1,077,700,000 1,091,000,000 1,083,500,000 1,106,200,000 1,042,600,000 996,600,000 1,038,000,000 1,054,400,000 1,023,500,000 1,024,900,000 1,037,600,000 1,145,300,000 957,600,000 998,900,000 982,200,000 1,047,700,000 748,400,000 746,200,000 
  accrued compensation744,600,000 759,300,000 900,400,000 799,900,000 671,900,000 708,100,000 851,400,000 751,400,000 694,700,000 759,400,000 916,500,000 854,700,000 886,000,000 840,100,000 976,300,000 810,900,000 729,700,000 661,700,000 720,500,000 627,100,000 555,300,000 637,900,000 888,800,000 666,700,000 621,400,000 580,000,000 817,900,000 874,900,000 834,200,000 
  income tax payable63,900,000 31,400,000 19,800,000 30,700,000 27,600,000 19,900,000 20,800,000 7,000,000 55,400,000 6,900,000 33,100,000 26,900,000 55,400,000 136,900,000 105,100,000 45,100,000 10,300,000 35,300,000 45,100,000 35,300,000 40,100,000 44,100,000 59,600,000 93,900,000 87,700,000 60,100,000 43,200,000 8,900,000 13,000,000 
  other current liabilities195,000,000 208,900,000 196,000,000 245,400,000 238,700,000 232,800,000 217,600,000 226,300,000 211,300,000 187,800,000 192,000,000 217,400,000 234,900,000 215,500,000 204,500,000 192,400,000 195,800,000 203,400,000 205,800,000 112,000,000 92,900,000 111,400,000 189,600,000 185,700,000 197,500,000 201,000,000 90,000,000 228,100,000 235,700,000 
  total current liabilities2,325,500,000 2,203,200,000 2,329,900,000 2,241,000,000 2,135,300,000 2,179,400,000 2,397,200,000 2,217,100,000 2,123,300,000 2,120,100,000 2,390,400,000 2,223,000,000 2,311,800,000 2,319,300,000 2,434,500,000 2,132,300,000 1,971,400,000 1,978,400,000 2,065,500,000 1,947,400,000 1,863,000,000 1,983,900,000 2,322,600,000 1,944,200,000 1,945,600,000 1,862,000,000 2,038,700,000 1,900,900,000 1,869,400,000 
  long-term debt2,820,400,000 2,910,500,000 2,939,600,000 2,997,000,000 3,001,700,000 3,065,900,000 3,096,900,000 3,125,200,000 3,226,400,000 3,228,000,000 3,211,700,000 3,211,600,000 3,212,200,000 3,215,900,000 3,220,500,000 3,223,000,000 3,225,900,000 3,230,500,000 3,235,700,000 3,239,500,000 3,243,000,000 2,611,100,000 2,620,300,000 2,625,300,000 2,631,300,000 2,639,100,000 2,644,200,000 2,646,500,000 3,002,200,000 
  deferred tax liabilities18,100,000 16,500,000 12,600,000 43,200,000 29,600,000 58,900,000 13,700,000 96,500,000 56,300,000 60,100,000 57,200,000 15,300,000 5,200,000 36,300,000 48,700,000 89,900,000 114,900,000 76,100,000 102,200,000 47,000,000 65,500,000 74,100,000 110,000,000 13,900,000 56,000,000 77,300,000 136,400,000 107,900,000 145,000,000 
  non-current operating lease liabilities246,600,000 254,800,000 270,300,000 279,800,000 283,800,000 296,900,000 319,600,000 305,600,000 324,300,000 332,800,000 334,600,000 331,200,000 359,800,000 377,800,000 394,600,000 411,600,000 383,300,000 378,900,000 405,600,000 415,400,000 424,200,000 443,300,000 457,100,000 468,500,000 491,600,000 492,900,000    
  other non-current liabilities240,700,000 245,600,000 241,400,000 270,000,000 253,100,000 264,600,000 268,600,000 266,500,000 287,800,000 301,200,000 293,300,000 262,400,000 258,400,000 268,300,000 343,500,000 382,900,000 393,000,000 360,100,000 433,300,000 402,800,000 421,500,000 422,600,000 352,100,000 368,300,000 346,400,000 305,800,000 366,600,000 368,000,000 389,500,000 
  total liabilities5,651,300,000 5,630,600,000 5,793,800,000 5,831,000,000 5,703,500,000 5,865,700,000 6,096,000,000 6,010,900,000 6,018,100,000 6,042,200,000 6,287,200,000 6,043,500,000 6,147,400,000 6,217,600,000 6,441,800,000 6,239,700,000 6,088,500,000 6,024,000,000 6,242,300,000 6,081,500,000 6,046,400,000 5,535,000,000 5,862,100,000 5,420,200,000 5,470,900,000 5,377,100,000 5,185,900,000 5,023,300,000 5,406,100,000 
  commitments and contingencies                             
  shareholders’ equity:                             
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 231,472,077 and 229,696,912 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively23,100,000                             
  additional paid-in capital3,006,200,000 2,992,200,000 2,986,400,000 2,970,700,000 2,959,400,000 2,954,600,000 2,957,300,000 2,943,900,000 2,929,800,000 2,916,100,000 2,911,500,000 2,901,500,000 2,892,000,000 2,880,000,000 2,896,600,000 2,871,700,000 2,854,300,000 2,846,500,000 2,843,400,000 2,835,100,000 2,832,700,000 2,822,100,000 2,819,500,000 2,810,900,000 2,814,300,000 2,801,400,000 2,791,200,000 2,789,200,000 1,770,600,000 
  accumulated deficit-926,700,000 -984,000,000 -985,900,000 -1,098,800,000 -1,132,500,000 -1,146,000,000 -1,117,200,000 -1,187,000,000 -1,153,100,000 -1,158,200,000 -1,081,800,000 -1,111,600,000 -1,135,500,000 -1,232,700,000 -1,278,200,000 -1,424,000,000 -1,492,700,000 -1,545,400,000 -1,528,200,000 -1,500,900,000 -1,463,600,000 -1,362,800,000 -1,297,000,000 -1,300,100,000 -1,311,800,000 -1,318,100,000 -1,298,400,000 -1,302,200,000 -1,253,500,000 
  accumulated other comprehensive loss-199,100,000 -254,900,000 -268,600,000 -192,400,000 -210,900,000 -206,700,000 -185,400,000 -208,600,000 -178,000,000 -201,600,000 -191,000,000 -235,100,000 -193,500,000 -132,200,000 -193,000,000 -234,200,000 -217,300,000 -217,500,000 -242,700,000 -310,300,000 -361,400,000 -396,800,000 -242,800,000 -298,100,000 -236,200,000 -174,600,000 -154,400,000 -98,800,000 -91,100,000 
  total equity attributable to the company1,903,500,000 1,776,400,000 1,754,900,000 1,702,400,000 1,638,900,000 1,624,800,000 1,677,400,000 1,571,000,000 1,621,400,000 1,579,000,000 1,661,300,000 1,577,400,000 1,585,600,000 1,537,700,000 1,447,800,000 1,235,800,000 1,166,600,000 1,105,900,000 1,094,700,000 1,046,100,000 1,029,400,000 1,084,200,000        
  non-controlling interests600,000 500,000 500,000 600,000 600,000 600,000 600,000 500,000 600,000 500,000 800,000 700,000 800,000 800,000 800,000 800,000 900,000 900,000 900,000 800,000 400,000 200,000        
  total equity1,904,100,000 1,776,900,000 1,755,400,000 1,703,000,000 1,639,500,000 1,625,400,000 1,678,000,000 1,571,500,000 1,622,000,000 1,579,500,000 1,662,100,000 1,578,100,000 1,586,400,000 1,538,500,000 1,448,600,000 1,236,600,000 1,167,500,000 1,106,800,000 1,095,600,000 1,046,900,000 1,029,800,000 1,084,400,000 1,301,300,000 1,234,200,000 1,288,000,000 1,330,400,000 1,360,100,000 1,409,100,000 440,600,000 
  total liabilities and shareholders’ equity7,555,400,000 7,407,500,000 7,549,200,000 7,534,000,000 7,343,000,000 7,491,100,000 7,774,000,000                       
  trade and other receivables, net of allowance of 89.0 and 88.7, as of march 31, 2025 and december 31, 2024, respectively 1,307,200,000                            
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 231,281,053 and 229,696,912 shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively 23,100,000                            
  trade and other receivables, net of allowance of 88.7 and 85.2 as of december 31, 2024 and 2023, respectively  1,352,400,000                           
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 229,696,912 and 227,282,173 shares issued and outstanding as of december 31, 2024 and 2023, respectively  23,000,000                           
  trade and other receivables, net of allowance of 89.4 and 85.2, as of september 30, 2024 and december 31, 2023, respectively   1,278,100,000                          
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 229,420,978 and 227,282,173 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively   22,900,000                          
  trade and other receivables, net of allowance of 87.8 and 85.2, as of june 30, 2024 and december 31, 2023, respectively    1,283,700,000                         
  assets held for sale    147,700,000                         
  liabilities associated with assets held for sale    23,000,000                         
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 229,191,378 and 227,282,173 shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively    22,900,000                         
  trade and other receivables, net of allowance of 85.1 and 85.2, as of march 31, 2024 and december 31, 2023, respectively     1,265,900,000                        
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 228,992,219 and 227,282,173 shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively     22,900,000                        
  trade and other receivables, net of allowance of 85.2 and 88.2 as of december 31, 2023 and 2022, respectively      1,468,000,000                       
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 227,282,173 and 225,780,535 shares issued and outstanding as of december 31, 2023 and 2022, respectively      22,700,000                       
  trade and other receivables, net of allowance of 82.2 and 88.2, as of september 30, 2023 and december 31, 2022, respectively       1,359,600,000                      
  liabilities and shareholders' equity                             
  shareholders' equity:                             
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 227,185,389 and 225,780,535 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively       22,700,000                      
  total liabilities and shareholders' equity       7,582,400,000 7,640,100,000 7,621,700,000 7,949,300,000 7,621,600,000 7,733,800,000 7,756,100,000 7,890,400,000 7,476,300,000 7,256,000,000 7,130,800,000 7,337,900,000 7,128,400,000 7,076,200,000 6,619,400,000 7,163,400,000 6,654,400,000 6,758,900,000 6,707,500,000 6,546,000,000 6,432,400,000 5,846,700,000 
  trade and other receivables, net of allowance of 82.2 and 88.2, as of june 30, 2023 and december 31, 2022, respectively        1,336,100,000                     
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 227,130,455 and 225,780,535 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively        22,700,000                     
  trade and other receivables, net of allowance of 86.0 and 88.2, as of march 31, 2023 and december 31, 2022, respectively         1,326,500,000                    
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 227,047,977 and 225,780,535 shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively         22,700,000                    
  trade and other receivables, net of allowance of 88.2 and 72.2 as of december 31, 2022 and 2021, respectively          1,462,400,000                   
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 225,780,535 and 223,709,308 shares issued and outstanding as of december 31, 2022 and 2021, respectively          22,600,000                   
  trade and other receivables, net of allowance of 80.2 million and 72.2 million, as of september 30, 2022 and december 31, 2021, respectively           1,323,400,000                  
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 225,756,656 and 223,709,308 shares issued and outstanding as of september 30, 2022 and december 31, 2021, respectively           22,600,000                  
  trade and other receivables, net of allowance of 79.8 million and 72.2 million, as of june 30, 2022 and december 31, 2021, respectively            1,540,400,000                 
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 225,663,686 and 223,709,308 shares issued and outstanding as of june 30, 2022 and december 31, 2021, respectively            22,600,000                 
  trade and other receivables, net of allowance of 78.2 million and 72.2 million, as of march 31, 2022 and december 31, 2021, respectively             1,372,700,000                
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 225,445,522 and 223,709,308 shares issued and outstanding as of march 31, 2022 and at december 31, 2021, respectively             22,600,000                
  trade and other receivables, net of allowance of 72.2 million and 70.9 million, as of december 31, 2021 and 2020, respectively              1,446,000,000               
  ordinary shares, nominal value 0.10 per share, 800,000,000 shares authorized; 223,709,308 and 221,960,472 shares issued and outstanding at december 31, 2021 and 2020, respectively              22,400,000               
  trade and other receivables, net of allowance of 77.7 million and 70.9 million, as of september 30, 2021 and december 31, 2020, respectively               1,284,800,000              
  ordinary shares, nominal value 0.10 per share, 223.4 and 222.0 shares issued and outstanding at september 30, 2021 and at december 31, 2020, respectively               22,300,000              
  trade and other receivables, net of allowance of 78.1 million and 70.9 million, as of june 30, 2021 and december 31, 2020, respectively                1,186,600,000             
  ordinary shares, nominal value 0.10 per share, 223.3 and 222.0 shares issued and outstanding at june 30, 2021 and at december 31, 2020, respectively                22,300,000             
  trade and other receivables, net of allowance of 77.6 million and 70.9 million, as of march 31, 2021 and december 31, 2020, respectively                 1,161,200,000            
  ordinary shares, nominal value 0.10 per share, 222.9 and 222.0 shares issued and outstanding at march 31, 2021 and at december 31, 2020, respectively                 22,300,000            
  trade and other receivables, net of allowance balance of 70.9 million and 58.4 million, as of december 31, 2020 and 2019, respectively                  1,301,600,000           
  ordinary shares, nominal value 0.10 per share, 222.0 shares issued and outstanding at december 31, 2020 and ordinary shares, nominal value 0.10 per share, 219.5 shares issued and outstanding at december 31, 2019                  22,200,000           
  trade and other receivables, net of allowance balance of 81.5 million and 58.4 million, as of september 30, 2020 and december 31, 2019, respectively                   1,210,500,000          
  prepaid expenses                   98,100,000 108,600,000         
  other current assets                   449,200,000 425,400,000         
  current operating lease liabilities                   112,100,000 111,700,000 114,100,000        
  long-term tax liabilities                   29,400,000 29,200,000         
  ordinary shares, nominal value 0.10 per share, 221.8 and 219.5 shares issued and outstanding at september 30, 2020 and at december 31, 2019, respectively                   22,200,000          
  trade and other receivables, net of allowance balance of 74.1 million and 58.4 million, as of june 30, 2020 and december 31, 2019, respectively                    1,184,700,000         
  ordinary shares, nominal value 0.10 per share, 220.8 and 219.5 shares issued and outstanding at june 30, 2020 and at december 31, 2019, respectively                    22,100,000         
  treasury stock                    -400,000 -400,000 -400,000 -400,000      
  trade and other receivables, net of allowance balance of 63.1 million and 58.4 million, as of march 31, 2020 and december 31, 2019, respectively                     1,244,600,000        
  ordinary shares, nominal value 0.10 per share, 220.5 and 219.5 shares issued and outstanding at march 31, 2020 and at december 31, 2019, respectively                     22,100,000        
  trade and other receivables, net of allowance balance of 58.4 million and 49.5 million,as of december 31, 2019 and 2018, respectively                      1,524,200,000       
  ordinary shares, nominal value 0.10 per share, 219.5 shares issued and outstanding at december 31, 2019 and ordinary shares nominal value 0.10 per share, 216.6 shares issued and outstanding at december 31, 2018                      22,000,000       
  trade and other receivables, net of allowance balance of 56.7 million and 49.5 million, as of september 30, 2019 and december 31, 2018, respectively                       1,352,000,000      
  ordinary shares, nominal value 0.10 per share, 219.0 and 216.6 shares issued and outstanding at september 30, 2019 and at december 31, 2018, respectively                       21,900,000      
  trade and other receivables, net of allowance balance of 57.5 million and 49.5 million, as of june 30, 2019 and december 31, 2018, respectively                        1,362,400,000     
  ordinary shares, nominal value 0.10 per share, 217.0 and 216.6 shares issued and outstanding at june 30, 2019 and at december 31, 2018, respectively                        21,700,000     
  trade and other receivables, net of allowance balance of 51.2 million and 49.5 million,as of march 31, 2019 and december 31, 2018, respectively                         1,370,900,000    
  ordinary shares, nominal value 0.10 per share, 216.7 and 216.6 shares issued and outstanding at march 31, 2019 and at december 31, 2018, respectively                         21,700,000    
  trade and other receivables, net of allowance balance of 49.5 million and 35.3 million,as of december 31, 2018 and 2017, respectively                          1,463,500,000   
  ordinary shares, nominal value 0.10 per share, 216.6 shares issued and outstanding at december 31, 2018 and ordinary shares nominal value 10.00 per share, 145.1 shares issued and outstanding at december 31, 2017                          21,700,000   
  trade and other receivables, net of allowance balance of 42.4 million and 35.3 million,as of september 30, 2018 and december 31, 2017, respectively                           1,299,900,000  
  ordinary shares, nominal value 0.10 per share, 208.7 issued and outstanding at september 30, 2018 and ordinary shares nominal value 10.00 per share, 145.1 shares issued and outstanding at december 31, 2017                           20,900,000  
  trade and other receivables, net of allowance balance of 44.1 million and 35.3 million,as of june 30, 2018 and december 31, 2017, respectively                            1,345,900,000 
  ordinary shares, nominal value 0.10 per share, 145.8 issued and outstanding at june 30, 2018 and ordinary shares nominal value 10.00 per share, 145.1 shares issued and outstanding at december 31, 2017                            14,600,000 

We provide you with 20 years of balance sheets for Cushman & Wakefield plc stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Cushman & Wakefield plc. Explore the full financial landscape of Cushman & Wakefield plc stock with our expertly curated balance sheets.

The information provided in this report about Cushman & Wakefield plc stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.